India to South Africa: Tenofovir Export Trade Route

The India to South Africa Tenofovir corridor is one of India's established pharmaceutical export routes, with 349 shipments documented worth a combined $115.2M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 30% of all export value, reflecting the consolidated nature of India's tenofovir manufacturing sector.

Across 21 active suppliers, the average shipment value stands at $330.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with tenofovir's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 13.0%, placing it at rank #3 among India's top tenofovir export destinations globally.

On the import side, key buyers of Indian tenofovir in South Africa include TO THE ORDER OF, VIATRIS HEALTHCARE (PTY) LTD,, EMCURE PHARMACEUTICALS SA (PTY) LTD and 55 others. TO THE ORDER OF is the single largest importer with 36 shipments valued at $22.2M USD.

India's tenofovir exports to South Africa are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 96 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 21 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, EMCURE PHARMACEUTICALS LIMITED — together account for 66% of total trade value on this route. The average shipment value of $330.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as acriptega tenofovirdisoproxilfumarate and dolutegravir+lamivudine+tenofovir disoprtablets, suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, TO THE ORDER OF is the largest importer with 36 shipments worth $22.2M USD — representing 19% of all tenofovir imports from India on this route. A total of 58 buyers are active on this corridor.